(Q36513108)

14 August 2017

Antiepileptic drugs 2012: recent advances and trends (English)

1 reference

14 August 2017

Joseph I Sirven

1

1 reference

14 August 2017

Katherine Noe

series ordinal

2

1 reference

14 August 2017

Matthew Hoerth

series ordinal

3

1 reference

14 August 2017

Joseph Drazkowski

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

14 August 2017

1 reference

14 August 2017

87

1 reference

14 August 2017

9

1 reference

14 August 2017

879-889

1 reference

The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Key factors in the discovery and development of new antiepileptic drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

30 September 2017

Vigabatrin: 2008 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Medical genetics: a marker for Stevens-Johnson syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

The pharmacologic basis of antiepileptic drug action

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Assessing bioequivalence of generic antiepilepsy drugs.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Vigabatrin therapy in infantile spasms: solving one problem and inducing another?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538494

Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958992

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Generic substitution in the treatment of epilepsy: patient and physician perceptions

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958992

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22958992

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.MAYOCP.2012.05.019

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22958992

1 reference